Modulating α-synuclein propagation and decomposition: implications in Parkinson's disease therapy

B Li, X Xiao, M Bi, Q Jiao, X Chen, C Yan, X Du… - Ageing Research …, 2024 - Elsevier
Abstract α-Synuclein (α-Syn) is closely related to the pathogenesis of Parkinson's disease
(PD). Under pathological conditions, the conformation of α-syn changes and different forms …

Modulation of alpha-synuclein conformational ensemble and aggregation pathways by dopamine and related molecules

A Natalello, S Brocca, E Ponzini… - FRONTIERS IN …, 2023 - boa.unimib.it
Dopaminergic neurons are constantly threatened by the thin boundaries between functional
α-synuclein (AS) structural disorder and pathogenic aggregation, and between dopamine …

Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease

V Brembati, G Faustini, F Longhena, TF Outeiro… - International Journal of …, 2023 - mdpi.com
Parkinson's disease (PD) pathology is characterized by the loss of dopaminergic neurons of
the nigrostriatal system and accumulation of Lewy bodies (LB) and Lewy neurites (LN) …

Secondary benefits of microsurgical intervention on the vertebral artery (V1 Segment) for refractory vertebrobasilar insufficiency: alleviation of Parkinsonism-like …

E Cekic, MB Surme, F Akbulut, R Ozturk, ME Ustun - World Neurosurgery, 2024 - Elsevier
Objective The objective of this study was to investigate the outcomes of microneurosurgical
interventions on V1 segment of the vertebral artery in patients with refractory vertebrobasilar …

Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers

SI Anjo, Z He, Z Hussain, A Farooq, A McIntyre… - Antioxidants, 2024 - mdpi.com
Oxidation–reduction post-translational modifications (redox-PTMs) are chemical alterations
to amino acids of proteins. Redox-PTMs participate in the regulation of protein conformation …

[HTML][HTML] MiR-29a efficiently suppresses the generation of reactive oxygen species and α-synuclein in a cellular model of Parkinson's disease by potentially targeting …

YL Yang, TK Lin, YH Huang - European Journal of Pharmacology, 2024 - Elsevier
Abstract MicroRNA-29a (miR-29a) has been suggested to serve a potential protective
function against Parkinson's disease (PD); however, the exact molecular mechanisms …

The Effects of Lipids on α-Synuclein Aggregation In Vitro

J Ramirez, SX Pancoe, E Rhoades, EJ Petersson - Biomolecules, 2023 - mdpi.com
The small neuronal protein α-synuclein (αS) is found in pre-synaptic terminals and plays a
role in vesicle recycling and neurotransmission. Fibrillar aggregates of αS are the hallmark …

Insight into the Effect of Methylglyoxal on the Conformation, Function, and Aggregation Propensity of α‐Synuclein

L Mariño, A Belén Uceda, F Leal… - Chemistry–A European …, 2024 - Wiley Online Library
It is well‐known that people suffering from hyperglycemia have a higher propensity to
develop Parkinson's disease (PD). One of the most plausible mechanisms linking these two …

Keeping neuronal activity in check: a novel role for α-synuclein serine-129 phosphorylation in the healthy brain

DE Mor - Trends in Biochemical Sciences, 2024 - cell.com
Phosphorylation of α-synuclein protein at serine-129 (Ser129P) is a widely used marker for
disease pathology in neurodegenerative disorders termed synucleinopathies. In …